The 36-month beta value for OPGN is also noteworthy at -0.71. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for OPGN is 9.97M, and at present, short sellers hold a 0.21% of that float. The average trading volume of OPGN on April 02, 2024 was 1.61M shares.
OPGN) stock’s latest price update
Opgen Inc (NASDAQ: OPGN) has seen a decline in its stock price by -14.17 in relation to its previous close of 0.69. However, the company has experienced a 19.54% gain in its stock price over the last five trading sessions. InvestorPlace reported 2023-09-29 that OpGen (NASDAQ: OPGN ) stock is on the rise Friday after the precision medicine company withdrew a share offering. A filing with the Securities and Exchange Commission (SEC) has the company requesting the withdrawal of its Registration Statement on Form S-1.
OPGN’s Market Performance
Opgen Inc (OPGN) has seen a 19.54% rise in stock performance for the week, with a 24.90% gain in the past month and a 35.57% surge in the past quarter. The volatility ratio for the week is 23.97%, and the volatility levels for the past 30 days are at 14.20% for OPGN. The simple moving average for the past 20 days is 8.85% for OPGN’s stock, with a 25.86% simple moving average for the past 200 days.
Analysts’ Opinion of OPGN
Many brokerage firms have already submitted their reports for OPGN stocks, with Alliance Global Partners repeating the rating for OPGN by listing it as a “Buy.” The predicted price for OPGN in the upcoming period, according to Alliance Global Partners is $2.30 based on the research report published on March 01, 2019 of the previous year 2019.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see OPGN reach a price target of $9, previously predicting the price at $1. The rating they have provided for OPGN stocks is “Buy” according to the report published on February 07th, 2018.
Rodman & Renshaw gave a rating of “Buy” to OPGN, setting the target price at $2.50 in the report published on June 29th of the previous year.
OPGN Trading at 33.73% from the 50-Day Moving Average
After a stumble in the market that brought OPGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.47% of loss for the given period.
Volatility was left at 14.20%, however, over the last 30 days, the volatility rate increased by 23.97%, as shares surge +2.07% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +128.72% upper at present.
During the last 5 trading sessions, OPGN rose by +19.54%, which changed the moving average for the period of 200-days by -5.63% in comparison to the 20-day moving average, which settled at $0.5486. In addition, Opgen Inc saw 42.02% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for OPGN
Current profitability levels for the company are sitting at:
- -5.98 for the present operating margin
- 0.07 for the gross margin
The net margin for Opgen Inc stands at -8.76. The total capital return value is set at -3.24. Equity return is now at value -314.91, with -102.41 for asset returns.
Based on Opgen Inc (OPGN), the company’s capital structure generated 0.82 points at debt to capital in total, while cash flow to debt ratio is standing at -1.33. The debt to equity ratio resting at 4.69. The interest coverage ratio of the stock is -7.86.
Currently, EBITDA for the company is -22.17 million with net debt to EBITDA at -0.7. When we switch over and look at the enterprise to sales, we see a ratio of 5.94. The receivables turnover for the company is 7.26for trailing twelve months and the total asset turnover is 0.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.28.
Conclusion
In summary, Opgen Inc (OPGN) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
